Skip to main content
. 2009 Feb 1;117(3):309–320. doi: 10.1007/s00401-009-0485-4

Table 1.

Description of the cases included

Case Gender Age at death years Clinical signs of dementia Primary cause of deatha Brain weight grams HP-ι Braak stage (10) β-amyloid phase (29) Type of CAAb when present (28)
1 Male 65 No 3 1,290 1 1 0
2 Male 82 No 2 1,595 1 1 0
3 Male 85 No 2 1,605 0 1 0
4 Male 64 No 3 1,510 0 2 0
5 Female 72 Yes 1 1,220 3 3 1
6 Female 88 No 1 1,195 1 3 2
7 Female 92 No 1 1,230 2 3 0
8 Male 70 No 1 1,540 2 3 2
9 Female 80 No 1 1,230 1 3 1
10 Female 90 Yes 2 1,260 3 3 2
11 Male 68 No 1 1,340 2 3 1
12 Male 84 No 2 1,370 1 3 1
13 Female 77 Yes 1 1,240 4 4 2
14 Female 95 Yes 2 1,175 4 4 2
15 Male 79 No 1 1,280 2 4 2
16 Female 76 Yes 2 1,200 3 4 0
17 Male 91 Yes 1 1,115 3 4 1
18 Female 82 Yes 2 1,215 5 4 2
19 Male 81 No 1 1,365 4 4 1
20 Female 84 Yes 1 1,365 4 4 1
21 Female 76 Yes 1 1,275 6 5 1
22 Male 76 Yes 1 1,440 6 5 2
23 Female 64 Yes 1 1,150 3 5 1
24 Female 68 Yes 2 1,400 6 5 1
25 Female 86 Yes 1 1,170 4 5 1
26 Male 73 Yes 2 1,390 3 5 2
27 Male 93 Yes 2 1,380 4 5 1
28 Female 82 Yes 2 1,315 5 5 1
29 Female 82 Yes 1 1,360 5 5 1
30 Female 80 Yes 2 1,250 4 5 1
31 Female 81 Yes 1 1,290 3 5 2
32 Male 72 Yes 1 1,245 3 5 2
33 Female 83 Yes 3 1,285 5 5 2
34 Female 61 No 1 1,425 1 5 1

The phase of β-amyloid deposition and the type of cerebral amyloid angiopathy (CAA) when present as assessed by the reference group

a1—cardiovascular, 2—infections, 3—neoplasia

b0—CAA not present, 1—CAA in capillaries with or without CAA in arteries and or veins, 2—CAA in arteries and veins